Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Drug Prices
Payers
DoseSpot study: Many patients are overpaying for GLP-1s
Concern about the cost of GLP-1s remains high, and a new study suggests it's not uncommon for patients to overpay for these drugs.
Paige Minemyer
Jun 23, 2025 6:00am
Iowa governor signs law tightening oversight of PBMs
Jun 16, 2025 4:07pm
PSG report: Employers weigh 'unbundling' PBM models, GLP-1s
Jun 10, 2025 9:30am
GOP Senators mull Medicare cuts in megabill
Jun 5, 2025 6:00pm
PBM Serve You Rx to add 2 Stelara biosimilars to its formulary
Jun 5, 2025 1:15pm
Scripta Insights, RxSaveCard team up on prescription discounts
Jun 2, 2025 4:15pm
